Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 02, 2015 11:19 AM ET


Company Overview of Genzyme Oncology, Inc.

Company Overview

As of June 2011, Genzyme Oncology, Inc. was acquired by Sanofi. Genzyme Oncology, Inc. focuses on developing and commercializing treatments for cancer patients. Its products are focused on the treatment of leukemia, lymphoma, and stem cell transplant. The company offers Campath, a recombinant DNA-derived humanized monoclonal antibody for the treatment of B-cell chronic lymphocytic leukemia; Clolar and Fludara that are purine nucleoside anti-metabolites for the treatment of pediatric patients with relapsed or refractory acute lymphoblastic leukemia; Leukine, a recombinant yeast derived human granulocyte macrophage colony-stimulating factor for adult patients with acute myelogenous leukemia; a...

55 Cambridge Parkway

Cambridge, MA 02142

United States

Founded in 1994

5,600 Employees





Key Executives for Genzyme Oncology, Inc.

Genzyme Oncology, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Anodyne Dental Pharma Inc. United States
G2B Pharma, Inc. United States
Vivelle Ventures LLC United States
Teva Neuroscience, Inc. United States
NeoRx Manufacturing Group, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Genzyme Oncology, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at